Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Micell Technologies Inc Company Overview 4
Micell Technologies Inc Company Snapshot 4
Micell Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Micell Technologies Inc – Pipeline Analysis Overview 6
Micell Technologies Inc – Key Facts 6
Micell Technologies Inc – Major Products and Services 7
Micell Technologies Inc Pipeline Products by Development Stage 8
Micell Technologies Inc Ongoing Clinical Trials by Trial Status 10
Micell Technologies Inc Pipeline Products Overview 12
Bioresorbable Scaffold (BRS) 12
Bioresorbable Scaffold (BRS) Product Overview 12
Drug-Coated Balloon 13
Drug-Coated Balloon Product Overview 13
MiStent SES 14
MiStent SES Product Overview 14
MiStent SES Clinical Trial 15
Peripheral Drug-Eluting Stent 17
Peripheral Drug-Eluting Stent Product Overview 17
Micell Technologies Inc – Key Competitors 18
Micell Technologies Inc – Key Employees 19
Micell Technologies Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Micell Technologies Inc, Recent Developments 21
May 23, 2018: Positive Two-Year Data from MiStent DESSOLVE III Trial Presented at EuroPCR – Excellent Safety And Low Target Lesion Revascularization (TLR) Rates Persist 21
Mar 20, 2018: Micell Technologies Announces Expanded Patent Estate 22
Jan 09, 2018: Positive Five-Year Data Published for MiStent in EuroIntervention 22
Dec 06, 2017: The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent Performance in All-Comers Randomized Trial; MiStent Achieved Primary Endpoint vs Xience 22
May 16, 2017: Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience 23
Nov 28, 2016: Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial Of MiStent In Japan 24
Oct 31, 2016: Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016 25
Mar 22, 2016: Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience 26
Feb 25, 2016: Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES and Market Standard Xience V Coronary Stent 27
Dec 09, 2015: Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial against Xience 28
Appendix 30
Methodology 30
About GlobalData 33
Contact Us 33
Disclaimer 33
Micell Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Micell Technologies Inc Pipeline Products by Equipment Type 5
Micell Technologies Inc Pipeline Products by Indication 5
Micell Technologies Inc Ongoing Clinical Trials by Trial Status 5
Micell Technologies Inc, Key Facts 6
Micell Technologies Inc, Major Products and Services 7
Micell Technologies Inc Number of Pipeline Products by Development Stage 8
Micell Technologies Inc Pipeline Products Summary by Development Stage 9
Micell Technologies Inc Ongoing Clinical Trials by Trial Status 10
Micell Technologies Inc Ongoing Clinical Trials Summary 11
Bioresorbable Scaffold (BRS) - Product Status 12
Bioresorbable Scaffold (BRS) - Product Description 12
Drug-Coated Balloon - Product Status 13
Drug-Coated Balloon - Product Description 13
MiStent SES - Product Status 14
MiStent SES - Product Description 14
MiStent SES - A Prospective, Single-blinded, Multi-center, Randomized, Controlled, Registered Clinical Trial on the Efficacy and Safety of Sirolimus-eluting Stent (MiStent System) in the Treatment of Patients with Coronary Heart Disease 15
MiStent SES - MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES) Optical Coherence Tomography (OCT) 15
MiStent SES - Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MiStent SES) for Revascularization of Coronary Arteries 15
MiStent SES - Multicenter Randomized Study of the Mistent Sirolimus Eluting Absorbable Polymer Stent System (MT005) for Revascularization of Coronary Arteries 16
Peripheral Drug-Eluting Stent - Product Status 17
Peripheral Drug-Eluting Stent - Product Description 17
Micell Technologies Inc, Key Employees 19
Glossary 32
List of Figures
Micell Technologies Inc Pipeline Products by Equipment Type 5
Micell Technologies Inc Pipeline Products by Development Stage 8
Micell Technologies Inc Ongoing Clinical Trials by Trial Status 10
【免責事項】
http://www.globalresearch.jp/disclaimer